Oxygen Therapy in Myocardial Infarction
Supplemental oxygen should NOT be routinely administered to patients with myocardial infarction who have oxygen saturations ≥90%, as it provides no cardiovascular benefit and may increase myocardial injury. 1, 2
When to Give Oxygen
Administer supplemental oxygen ONLY when:
- Oxygen saturation is confirmed <90% on pulse oximetry 1, 2
- Target: titrate to achieve oxygen saturation ≥90% 1, 2
When NOT to Give Oxygen
Do NOT give supplemental oxygen when:
- Oxygen saturation is ≥90% 1, 2
- This applies even to patients with saturations in the "low-normal" range of 90-94% 1
Evidence Supporting This Approach
The 2025 ACC/AHA/ACEP/NAEMSP/SCAI guidelines provide a Class 1 (recommended) indication for oxygen only in hypoxic patients (SpO₂ <90%) and a Class 3: No Benefit recommendation against routine oxygen in normoxic patients. 1, 2
Key Trial Data:
DETO2X-AMI trial (6,629 patients): Routine oxygen at 6 L/min in patients with SpO₂ ≥90% showed no reduction in 1-year mortality or rehospitalization for MI, even in those with baseline saturations of 90-94%. 1, 3
AVOID trial: Oxygen at 8 L/min in STEMI patients with SpO₂ ≥94% demonstrated possible harm, including increased myocardial injury (27% higher peak creatine kinase), larger infarct size on cardiac MRI at 6 months, higher rates of recurrent MI (5.5% vs 0.9%), and more cardiac arrhythmias (40.4% vs 31.4%). 1, 4
Meta-analyses confirm no mortality benefit from routine oxygen therapy in normoxic MI patients. 5, 6
Mechanism of Potential Harm:
Supplemental oxygen in normoxic patients may cause:
The relationship between oxygenation and outcomes is U-shaped, with the lowest mortality observed at SpO₂ of 94-96% at presentation. 1
Common Pitfalls to Avoid
Do not reflexively order oxygen for all MI patients - this outdated practice persists despite clear evidence of lack of benefit. 1, 2
Do not assume "more oxygen is better" - liberal oxygen administration is associated with worse outcomes compared to conservative use. 1
Do not skip oxygen saturation monitoring - always confirm hypoxia before initiating oxygen therapy. 1, 2
Special Populations
Patients excluded from major trials (where clinical judgment is needed):
- Home oxygen requirement 1
- Active bronchospasm requiring supplemental oxygen 1
- Cardiac arrest at presentation 1
ICU patients with MI: Recent data suggest early supplemental oxygen in normoxic ICU patients with MI (SpO₂ 92-96%) is associated with increased 365-day mortality (adjusted HR 1.477), particularly in those with COPD. 7